S&P 500
$5,802.82
-0.7%
-$39.19
DJI
$41,603.07
-0.6%
-$256.02
NASDAQ
$18,737.21
-1.0%
-$188.53
Bitcoin
107,830.00
-0.3%
-274.58
AAPL
$195.55
-2.9%
-$5.81
AMZN
$201.33
-0.9%
-$1.77
GOOG
$169.68
-1.3%
-$2.30
META
$627.70
-1.4%
-$8.87
MSFT
$451.11
-0.8%
-$3.75
NVDA
$131.48
-1.0%
-$1.36
TSLA
$339.93
-0.3%
-$1.11
Alex Carchidi
TMFacarchidi
Alex began writing for the Fool in early 2020 and follows companies in the healthcare sector. Formerly a researcher in the biotech industry, he leverages his science background in his work as a writer and entrepreneur. His interests include exploring his hometown of Boston, traveling in Latin America, and value investing.
Recent Articles by Alex Carchidi

Dec 15, 2024
by Alex Carchidi
Where Will Teladoc Health Be in 3 Years?

Dec 15, 2024
by Alex Carchidi
Is Pfizer a Millionaire Maker?

Dec 2, 2024
by Alex Carchidi
Is Bristol-Myers Squibb Stock a Millionaire Maker?

Nov 30, 2024
by Alex Carchidi
Is Medical Properties Trust Stock a Buy?

Nov 30, 2024
by Alex Carchidi
Warning: This Skyrocketing Stock Has a Hidden Risk

Nov 29, 2024
by Alex Carchidi
Is Novo Nordisk Stock a Buy?

Nov 27, 2024
by Alex Carchidi
Is Tilray Brands Stock a Buy?

Nov 24, 2024
by Alex Carchidi
Where Will Bristol Myers Squibb Be in 5 Years?

Nov 22, 2024
by Alex Carchidi
Investing in Pharma Stocks? Check These 3 Things First

Nov 19, 2024
by Alex Carchidi
Where Will AbbVie Be in 5 Years?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.